Den Boer M O, Somers J A, Saxena P R
Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, The Netherlands.
Cephalalgia. 1992 Aug;12(4):206-13. doi: 10.1046/j.1468-2982.1992.1204206.x.
The haemodynamic effects of sumatriptan, a 5-HT1-like receptor agonist, and ergotamine, an agonist at alpha-adrenergic, dopamine as well as 5-HT receptors, were compared using intracardiac injection of radioactive microspheres of different sizes in anaesthetized pigs. Ergotamine (0.02 mg.kg-1) and sumatriptan (0.3 mg.kg-1) decreased systemic vascular conductance and cardiac output. Only ergotamine raised arterial blood pressure. Both sumatriptan and ergotamine decreased arteriovenous anastomotic, but not capillary, blood flow in the head and body skin. Arteriovenous and capillary blood flow in the dura mater and nasal mucosa and capillary blood flow in the brain, kidneys, adrenals, intestine, heart, spleen and muscle remained unchanged. However, kidney conductance was decreased by both drugs, spleen conductance by sumatriptan and heart, liver and adrenal conductances were decreased by ergotamine. Thus, both sumatriptan and ergotamine constricted arteriovenous anastomoses in the skin, but not in the dura mater or nasal mucosa. Ergotamine constricted the vasculature more than sumatriptan, although both drugs may differentially decrease vascular conductances in some organs.
使用不同大小的放射性微球心内注射法,在麻醉猪身上比较了5 - HT1样受体激动剂舒马曲坦和α - 肾上腺素能、多巴胺以及5 - HT受体激动剂麦角胺的血流动力学效应。麦角胺(0.02mg·kg-1)和舒马曲坦(0.3mg·kg-1)降低了全身血管传导率和心输出量。只有麦角胺升高了动脉血压。舒马曲坦和麦角胺均降低了头部和身体皮肤的动静脉吻合支血流量,但未降低毛细血管血流量。硬脑膜、鼻黏膜的动静脉和毛细血管血流量以及脑、肾、肾上腺、肠、心脏、脾脏和肌肉的毛细血管血流量均保持不变。然而,两种药物均降低了肾脏传导率,舒马曲坦降低了脾脏传导率,麦角胺降低了心脏、肝脏和肾上腺传导率。因此,舒马曲坦和麦角胺均使皮肤中的动静脉吻合支收缩,但硬脑膜或鼻黏膜中的动静脉吻合支未收缩。麦角胺比舒马曲坦更能使血管收缩,尽管两种药物可能会不同程度地降低某些器官的血管传导率。